Raab & Moskowitz Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.44M | Sell |
226,116
-6,128
| -3% | -$160K | 1.1% | 26 |
|
|
2026
Q1 | $6.52M | Sell |
232,244
-8,720
| -4% | -$232K | 1.45% | 18 |
|
|
2025
Q4 | $6M | Sell |
240,964
-39,910
| -14% | -$1.01M | 1.31% | 19 |
|
|
2025
Q3 | $7.16M | Sell |
280,874
-3,230
| -1% | -$79.7K | 1.6% | 17 |
|
|
2025
Q2 | $6.89M | Sell |
284,104
-7,953
| -3% | -$185K | 1.64% | 16 |
|
|
2025
Q1 | $7.4M | Buy |
292,057
+6,490
| +2% | +$170K | 1.86% | 14 |
|
|
2024
Q4 | $7.58M | Buy |
285,567
+26,433
| +10% | +$717K | 1.86% | 14 |
|
|
2024
Q3 | $7.5M | Buy |
259,134
+20,197
| +8% | +$589K | 1.9% | 12 |
|
|
2024
Q2 | $6.69M | Buy |
238,937
+82,497
| +53% | +$2.27M | 1.82% | 14 |
|
|
2024
Q1 | $4.34M | Buy |
156,440
+22,693
| +17% | +$630K | 1.21% | 22 |
|
|
2023
Q4 | $3.85M | Buy |
133,747
+1,884
| +1% | +$57K | 1.22% | 23 |
|
|
2023
Q3 | $4.37M | Buy |
131,863
+5,325
| +4% | +$188K | 1.54% | 18 |
|
|
2023
Q2 | $4.64M | Sell |
126,538
-1,096
| -0.9% | -$42.7K | 1.59% | 17 |
|
|
2023
Q1 | $5.21M | Sell |
127,634
-700
| -0.5% | -$30.2K | 1.9% | 9 |
|
|
2022
Q4 | $6.58M | Buy |
128,334
+2,131
| +2% | +$102K | 2.5% | 7 |
|
|
2022
Q3 | $5.52M | Sell |
126,203
-7,124
| -5% | -$346K | 2.32% | 7 |
|
|
2022
Q2 | $6.99M | Buy |
133,327
+1,312
| +1% | +$66.9K | 2.74% | 4 |
|
|
2022
Q1 | $6.83M | Sell |
132,015
-3,797
| -3% | -$197K | 2.34% | 7 |
|
|
2021
Q4 | $8.02M | Sell |
135,812
-1,426
| -1% | -$70.7K | 2.63% | 5 |
|
|
2021
Q3 | $5.9M | Sell |
137,238
-685
| -0.5% | -$30.3K | 2.13% | 8 |
|
|
2021
Q2 | $5.4M | Sell |
137,923
-815
| -0.6% | -$31.7K | 1.98% | 10 |
|
|
2021
Q1 | $5.03M | Sell |
138,738
-249
| -0.2% | -$8.84K | 1.96% | 10 |
|
|
2020
Q4 | $5.12M | Sell |
138,987
-8,562
| -6% | -$314K | 2.1% | 11 |
|
|
2020
Q3 | $5.14M | Sell |
147,549
-4,774
| -3% | -$167K | 2.37% | 7 |
|
|
2020
Q2 | $4.72M | Buy |
152,323
+584
| +0.4% | +$19.8K | 2.29% | 6 |
|
|
2020
Q1 | $4.7M | Buy |
151,739
+6,979
| +5% | +$238K | 2.56% | 4 |
|
|
2019
Q4 | $5.38M | Buy |
144,760
+1,336
| +0.9% | +$47.6K | 2.13% | 5 |
|
|
2019
Q3 | $4.89M | Sell |
143,424
-250
| -0.2% | -$9.09K | 2.14% | 5 |
|
|
2019
Q2 | $5.91M | Buy |
143,674
+4,317
| +3% | +$171K | 2.62% | 2 |
|
|
2019
Q1 | $5.62M | Sell |
139,357
-593
| -0.4% | -$23.7K | 2.57% | 2 |
|
|
2018
Q4 | $5.79M | Sell |
139,950
-8,046
| -5% | -$334K | 2.85% | 3 |
|
|
2018
Q3 | $6.19M | Buy |
147,996
+3,761
| +3% | +$145K | 2.57% | 2 |
|
|
2018
Q2 | $4.96M | Sell |
144,235
-5,484
| -4% | -$187K | 2.37% | 5 |
|
|
2018
Q1 | $5.04M | Sell |
149,719
-1,668
| -1% | -$57.3K | 2.48% | 4 |
|
|
2017
Q4 | $5.2M | Sell |
151,387
-4,211
| -3% | -$144K | 2.51% | 5 |
|
|
2017
Q3 | $5.17M | Sell |
155,598
-2,801
| -2% | -$90K | 2.5% | 5 |
|
|
2017
Q2 | $5.02M | Buy |
158,399
+706
| +0.4% | +$22.3K | 2.5% | 5 |
|
|
2017
Q1 | $5.12M | Sell |
157,693
-1,020
| -0.6% | -$32.2K | 2.67% | 6 |
|
|
2016
Q4 | $4.89M | Sell |
158,713
-221
| -0.1% | -$6.75K | 2.65% | 6 |
|
|
2016
Q3 | $5.11M | Sell |
158,934
-4,115
| -3% | -$138K | 2.88% | 4 |
|
|
2016
Q2 | $5.45M | Sell |
163,049
-5,549
| -3% | -$177K | 3.1% | 3 |
|
|
2016
Q1 | $4.74M | Sell |
168,598
-939
| -0.6% | -$26.8K | 2.82% | 4 |
|
|
2015
Q4 | $5.19M | Buy |
169,537
+1,627
| +1% | +$51.2K | 3.09% | 4 |
|
|
2015
Q3 | $5M | Sell |
167,910
-517
| -0.3% | -$16.6K | 3.23% | 2 |
|
|
2015
Q2 | $5.36M | Buy |
168,427
+5,143
| +3% | +$168K | 3.3% | 1 |
|
|
2015
Q1 | $5.39M | Sell |
163,284
-7,734
| -5% | -$246K | 3.27% | 2 |
|
|
2014
Q4 | $5.05M | Sell |
171,018
-54,243
| -24% | -$1.56M | 2.89% | 3 |
|
|
2014
Q3 | $6.32M | Buy |
225,261
+7,613
| +3% | +$214K | 3.07% | 3 |
|
|
2014
Q2 | $6.13M | Buy |
217,648
+38,905
| +22% | +$1.11M | 2.92% | 3 |
|
|
2014
Q1 | $5.45M | Sell |
178,743
-27,389
| -13% | -$817K | 3.01% | 3 |
|
|
2013
Q4 | $5.64M | Buy |
+206,132
| New | +$6M | 3.24% | 1 |
|
Other funds holding PFE
Raab & Moskowitz Asset Management's PFE Position: Q2 2026 in Review
Raab & Moskowitz Asset Management reduced its Pfizer (PFE) stake by 2.6% in Q2 2026, selling an estimated $160K and leaving 226,116 shares worth $5.44M. The position accounts for 1.1% of the portfolio, ranked #26.
Raab & Moskowitz Asset Management first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $8.02M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Raab & Moskowitz Asset Management held 226,116 shares of Pfizer worth $5.44M as of Q2 2026.
- Raab & Moskowitz Asset Management sold 6,128 Pfizer shares in Q2 2026, an estimated $160K.
- Pfizer made up 1.1% of Raab & Moskowitz Asset Management's portfolio in Q2 2026, its #26 holding.
- Raab & Moskowitz Asset Management first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
- Raab & Moskowitz Asset Management's Pfizer position peaked at $8.02M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Raab & Moskowitz Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.